Quincy Medical Group announces availability of innovative, in-office treatment for chronic nasal airway obstruction

Quincy Medical Group (QMG) is pleased to announce the availability of VivAer®, a minimally-invasive FDA-cleared technology that provides lasting relief from chronic nasal airway obstruction.

QMG Ear, Nose, and Throat (ENT) physicians Dr. Paul Conrad and Dr. Abraham Sheffield offer this new treatment option for patients. Nasal airway obstruction is one of the most common but often undiagnosed conditions; more than 20 million Americans suffer from nasal obstruction in the United States.

Nasal obstruction is often caused by anatomical blockage in the nose, hindering airflow. As a result, patients may feel congested or “stuffy.” Common symptoms include nasal congestion or stuffiness, trouble breathing through the nose, trouble sleeping, and difficulty breathing well during exercise or exertion. For many patients, management of this condition with medications and sprays is inadequate or offers only temporary relief.

“If you regularly experience difficulty breathing through your nose, especially at night, and nothing seems to help but decongestants or Breathe Rights, you likely have enlarged nasal turbinates and/or nasal valve collapse,” said Dr. Conrad. “Until recently, finding a long-term solution for these problems often meant surgery. Now, with VivAer, we’re able to offer an in office convenient, minimally-invasive procedure that gradually opens your nasal airway to help you breathe better.”

VivAer features a thin, wand-like, temperature-controlled stylus that attaches to a console. The stylus is inserted via the nostril to gently remodel the nasal tissue and improve air flow using patented temperature-controlled radiofrequency technology that delivers precise therapeutic benefits. Treatment with VivAer can be performed with a local anesthetic during a routine office visit, with no incisions, minimal to no downtime, and minimal discomfort. Patients typically return to normal activity on the same day.

“Chronic nasal obstruction can greatly affect a person’s quality of life,” said Dr. Sheffield. “Finding the most appropriate treatment for each individual is our top priority. We are excited to offer patients this new treatment option.”

For more information or to schedule a consultation, call (217) 222-6550, ext. 6900 or visit quincymedgroup.com/vivaer.